WebOct 12, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebJun 17, 2024 · [email protected] +33 153 198 757. French Media: FP2COM Florence Portejoie [email protected] ... This press release includes only summary …
OSE Immunotherapeutics Appoints Nicolas Poirier as Chief
WebApr 4, 2024 · Boehringer Ingelheim and OSE Immunotherapeutics enter into a global license and collaboration agreement in immuno-oncology to develop OSE-172, a novel … WebMar 11, 2024 · Immuno-oncology platform. BI 765063 (OSE-172, anti-SIRPα mAb on SIRPα/CD47 pathway): ... This press release includes only summary information and … coby\u0027s speech one piece
OSE Immunotherapeutics Announces New European Patent …
WebJun 24, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebJul 13, 2024 · NANTES, France, July 13, 2024 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the appointment of Alexis Vandier as Chief Executive Officer, effective immediately. Alexis Vandier brings an impressive track record of successes in Pharma across a range of … WebOct 11, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2024, including the... coby\\u0027s wrecker service port lavaca